Levamisole as an adjuvant to hepatitis B vaccination in patients with chronic kidney disease
Journal of Analytical Research in Clinical Medicine · 2015
DOI: 10.15171/jarcm.2015.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Analytical Research in Clinical Medicine, 2015. Verfasst von Mohammad-Hossein Somi und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Somi, M., Ardalan, M., Moghadaszadeh, M., Shirmohamadi, M., Piri, R., & Naghavi-Behzad, M. (2015). Levamisole as an adjuvant to hepatitis B vaccination in patients with chronic kidney disease. Journal of Analytical Research in Clinical Medicine. https://doi.org/10.15171/jarcm.2015.013
Vancouver
Somi M, Ardalan M, Moghadaszadeh M, Shirmohamadi M, Piri R, Naghavi-Behzad M. Levamisole as an adjuvant to hepatitis B vaccination in patients with chronic kidney disease. Journal of Analytical Research in Clinical Medicine. 2015. doi:10.15171/jarcm.2015.013
BibTeX
@article{Somi2015,
author = {Somi, Mohammad-Hossein and Ardalan, Mohammad-Reza and Moghadaszadeh, Majid and Shirmohamadi, Masoud and Piri, Reza and Naghavi-Behzad, Mohammad},
title = {Levamisole as an adjuvant to hepatitis B vaccination in patients with chronic kidney disease},
journal = {Journal of Analytical Research in Clinical Medicine},
year = {2015},
doi = {10.15171/jarcm.2015.013}
}
EUVIMED